Karolina Pawłuszkiewicz

Mrs. Karolina Pawłuszkiewicz

Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
KPKarolina Pawłuszkiewicz
Karolina Pawłuszkiewicz
PRPiotr Józef Ryglowski
Piotr Józef Ryglowski
NINatalia Zofia Idzik
Natalia Zofia Idzik
KBKatarzyna Błaszczyszyn
Katarzyna Błaszczyszyn
EKEmilia Kucharczyk
Emilia Kucharczyk
Emil Albert PaluchEmil Albert Paluch
Emil Albert Paluch
Rotavirus (RV) is the most common cause of severe acute gastroenteritis (AGE) in children under five years of age. This review summarizes current knowledge on RV infections, with a particular focus on viral structure, pathophysiological mechanisms, and age-dependent clinical presentation. Special attention is given to systemic manifestations, including central nervous system involvement, autoimmune responses such as type 1 diabetes and celiac disease, and rare associations with biliary atresia. The mechanisms of RV-induced diarrhea and vomiting are discussed in detail. Clinical severity scoring systems—such as the Vesikari and Clark scales—and dehydration assessment tools—the Clinical Dehydration Scale (CDS) and the Dehydration: Assessing Kids Accurately (DHAKA) score—are compared. The review highlights differences in disease course between children under and over five years, emphasizing that RV is not limited to early childhood. A major section addresses the global effectiveness of vaccination programs, their role in reducing disease burden, coverage challenges, and decreased efficacy in low-income countries. Particular focus is placed on high-risk groups, including preterm and immunocompromised infants.

Verified
Journal Article
Open access
PDF file
KPKarolina Pawłuszkiewicz
Karolina Pawłuszkiewicz
TBTomasz Busłowicz
Tomasz Busłowicz
MKMatylda Jagoda Korgiel
Matylda Jagoda Korgiel
AFAnita Maria Faltus
Anita Maria Faltus
EKEmilia Kucharczyk
Emilia Kucharczyk
Emil Albert PaluchEmil Albert Paluch
Emil Albert Paluch
The increasing incidence of hospital-acquired infections and antimicrobial-resistant pathogens poses a major clinical challenge. Nearly all medical devices are vulnerable to bacterial biofilm formation, which acts as a protective coating against the host defense systems and antibiotics. The persistence of biofilm infections, accounting for around 65% of all microbial infections, and poor conventional treatment outcomes has driven interest in alternative approaches like bacteriophage therapy. This review encompasses key aspects of biofilm biology, taking into account the clinically significant ESKAPE pathogens, and provides an in-depth analysis of the role of phage agents in biofilm control as a new biofilm control strategy. Diving deeper into the mechanisms of phage-mediated processes, the review examines how bacteriophages penetrate and disrupt biofilm architecture and evaluates current therapeutic strategies that exploit these actions, acknowledging their limitations and considering possible future directions.

Verified
Journal Article
Open access
PDF file
EKEmilia Kucharczyk
Emilia Kucharczyk
KPKarolina Pawłuszkiewicz
Karolina Pawłuszkiewicz
KBKarol Bilinski
Karol Bilinski
JMJoanna Maj
Joanna Maj
MPMałgorzata Ponikowska
Małgorzata Ponikowska
Cutaneous warts caused by human papillomavirus (HPV) are among the most common dermatological conditions, affecting the quality of life of numerous people. Although they are widespread, effective and reliable treatment alternatives are limited, emphasizing the necessity for novel treatment options. Intralesional immunotherapy has emerged as a promising alternative, aiming to stimulate the host immune response to achieve the clearance of both treated and distant lesions. This review explores the immunopathogenesis of cutaneous warts and provides an in-depth analysis of intralesional therapies including measles–mumps–rubella (MMR) vaccine, purified protein derivative (PPD), Bacillus Calmette–Guérin (BCG), Candida antigen, Mycobacterium w vaccine (MWV), vitamin D3, and autoinoculation. We provide a comprehensive analysis of the most promising modalities, highlighting their mechanism of action, outcomes, advantages, and limitations. Although initial data indicate that intralesional immunotherapy offers advantageous efficacy and tolerability, there is a lack of standardized treatment protocols and randomized controlled trials to endorse its broad application. Nevertheless, considering its potential to address local and distant lesions with minimal adverse effects, intralesional immunotherapy may represent a transformative approach to managing cutaneous warts.

Verified
Journal Article
Open access
PDF file
DNDanuta Nowicka
Danuta Nowicka
EKEmilia Kucharczyk
Emilia Kucharczyk
KPKarolina Pawłuszkiewicz
Karolina Pawłuszkiewicz
MKMatylda Jagoda Korgiel
Matylda Jagoda Korgiel
TBTomasz Busłowicz
Tomasz Busłowicz
MPMałgorzata Ponikowska
Małgorzata Ponikowska
The skin microbiome plays a pivotal role in maintaining skin homeostasis, immune regulation, and barrier integrity. Dysbiosis, characterized by altered diversity and function of the microflora, contributes to the pathogenesis of chronic inflammatory dermatoses such as atopic dermatitis, psoriasis, acne vulgaris, hidradenitis suppurativa, rosacea, and photoaging. This narrative review, based on searches in PubMed, Scopus, and Google Scholar, summarizes current evidence on the role of topical probiotics in the prevention and management of inflammatory dermatoses, drawing mainly on studies from the past decade and, where relevant, earlier works published between 1975 and 2025. Evidence indicates that topical probiotics modulate local immune responses, enhance antimicrobial peptide synthesis, inhibit pathogenic microorganism colonization, and support skin barrier regeneration. Additional benefits include accelerated wound healing and reduced environmental damage. However, study results are heterogeneous, and designs vary, with limited data on long-term effects, particularly in paediatric and immunosuppressed populations. Topical probiotics are a promising therapeutic approach for chronic inflammatory dermatoses linked to microbiota dysbiosis. They can restore microbial balance, support barrier function, suppress pathogenic microorganisms, and promote skin regeneration. Despite consistent reports of clinical improvement and improved cutaneous defence mechanisms, small sample sizes, methodological heterogeneity, and the absence of standardized dosing regimens limit current evidence. Long-term safety data are limited, especially for vulnerable patient groups. Rigorous randomized controlled trials with standardized protocols and larger, diverse populations are needed to confirm efficacy, ensure safety, and guide clinical implementation.

29 April 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
Emilia Maria NowakEmilia Maria Nowak
Emilia Maria Nowak
MKMatylda Jagoda Korgiel
Matylda Jagoda Korgiel
KPKarolina Pawłuszkiewicz
Karolina Pawłuszkiewicz
JWJarosław Widelski
Jarosław Widelski
BCBachar Cheaib
Bachar Cheaib
Emil Albert PaluchEmil Albert Paluch
Emil Albert Paluch
Antimicrobial resistance (AMR) represents a major global health threat, largely driven by antibiotic overuse and the protective role of bacterial biofilms. Quorum sensing (QS), a bacterial communication system regulating virulence and biofilm formation, has emerged as a promising therapeutic target. Quorum quenching (QQ), which disrupts QS without directly inhibiting bacterial growth, is considered a potential anti-virulence strategy that may reduce selective pressure for resistance. This review critically evaluates recent advances in QQ research, focusing on its clinical applicability, limitations, and risks. We analyzed studies from the last five years involving natural compounds, synthetic molecules, nanoparticles (NPs), and combination therapies targeting key pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus in models of lung diseases, mainly cystic fibrosis, chronic wounds, burns, and implant-associated infections. While numerous compounds demonstrate significant in vitro anti-biofilm and anti-virulence activity, major challenges remain, including limited in vivo validation, pharmacokinetic constraints, toxicity concerns, microbiome disruption, and the potential development of tolerance or functional resistance. Although QQ offers a promising adjunctive approach to conventional antibiotics, its long-term clinical feasibility requires comprehensive evaluation of evolutionary dynamics, host–microbe interactions, and safety profiles.

Verified
Journal Article
Open access
PDF file
KPKarolina Pawłuszkiewicz
Karolina Pawłuszkiewicz
EKEmilia Kucharczyk
Emilia Kucharczyk
MKMatylda Jagoda Korgiel
Matylda Jagoda Korgiel
TBTomasz Busłowicz
Tomasz Busłowicz
AFAnita Maria Faltus
Anita Maria Faltus
Emil Albert PaluchEmil Albert Paluch
Emil Albert Paluch
Rotavirus remains one of the leading causes of severe gastroenteritis, particularly among infants and young children, despite the introduction of effective vaccines. Although the global burden of rotavirus-associated morbidity and mortality has decreased in recent years, significant challenges remain regarding accurate diagnosis, optimal clinical management, and equitable access to preventive measures. The aim of this narrative review is to provide a comprehensive synthesis of recent advances in the diagnosis and treatment of rotavirus infections. Particular emphasis is placed on post-guideline research emerging after the publication of the Evidence-Based Guidelines from the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) and the European Society for Pediatric Infectious Diseases (ESPID), offering updated perspectives on therapeutic strategies and clinical practices. In addition, this review discusses the expanding role of molecular diagnostic methods, which offer enhanced sensitivity and specificity in the detection of rotavirus, and evaluates novel antiviral agents under investigation. By integrating and analyzing the most relevant research published within the past decade, we aim to delineate key progress, identify persistent gaps in knowledge, and propose future directions for research and clinical application.